Year 2022 / Volume 114 / Number 9
Digestive Diseases Image
Immune-mediated colitis secondary to treatment with nivolumab-ipilimumab in a patient with stage IV kidney cancer: what do we do when corticosteroids fail?

554-555

DOI: 10.17235/reed.2022.8632/2022

Manuel Sánchez Cánovas, Aurelio López Martín, Sofía Montenegro Luis, Ana Sánchez Saura,

Abstract
52-year-old male. The patient had a stage IV renal carcinoma with bone metastases. He started first-line treatment with nivolumab (3 mg/kg) associated with ipilimumab (1 mg/kg). After two cycles of treatment, the patient reported hemorrhagic diarrhoea (7 to 10 stools daily), with visceral nociceptive abdominal pain of moderate intensity and oral intolerance.
Share Button
New comment
Comments
No comments for this article
References
1. Schneider BJ, Naidoo J, Santomasso BD, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. J Clin Oncol. 2021 Dec 20;39(36):4073-4126. doi: 10.1200/JCO.21.01440. Epub 2021 Nov 1. Erratum in: J Clin Oncol. 2022 Jan 20;40(3):315. PMID: 34724392.
2. Majem M, García-Martínez E, Martinez M, et al. SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019). Clin Transl Oncol. 2020 Feb;22(2):213-222. doi: 10.1007/s12094-019-02273-x. Epub 2020 Jan 28. PMID: 31993963.
Luque Carmona AM, Ontanilla-Clavijo G, Leo Carnerero E. Severe enterocolitis secondary to ipilimumab and nivolumab with an excellent response to a single dose of infliximab. Rev Esp Enferm Dig. 2020 Nov;112(11):889-890. doi: 10.17235/reed.2020.6886/2020. PMID: 33054275.
Related articles

Editorial

Pancreatic cancer screening in high-risk individuals

DOI: 10.17235/reed.2024.10635/2024

Editorial

Different trends in stomach and pancreatic cancer mortality rates

DOI: 10.17235/reed.2024.10504/2024

Digestive Diseases Image

Spontaneous regression of a rectal cancer

DOI: 10.17235/reed.2023.9486/2023

Letter

Vaginal lesion as first manifestation of colorectal disease

DOI: 10.17235/reed.2022.9270/2022

Digestive Diseases Image

A case of esophageal histoplasmosis mimicking carcinoma on endoscopy

DOI: 10.17235/reed.2023.9167/2022

Editorial

Drug induced liver injury by immunotherapy

DOI: 10.17235/reed.2022.9179/2022

Review

Immunotherapy in hepatocellular carcinoma

DOI: 10.17235/reed.2022.8876/2022

Letter

Cytomegalovirus colitis seems to be colon cancer. HIV debut

DOI: 10.17235/reed.2022.8699/2022

Letter

Sigmoid colon Schwannoma simulating colon cancer

DOI: 10.17235/reed.2022.8684/2022

Letter

Wernicke encephalopathy following advanced caecum cancer

DOI: 10.17235/reed.2021.8343/2021

Letter

Anal neoplasia and perianal Crohn’s disease: myth or reality?

DOI: 10.17235/reed.2021.8317/2021

Review

Inflammatory bowel disease and solid organ transplantation

DOI: 10.17235/reed.2020.7361/2020

Review

New non-invasive biomarkers for colorectal cancer screening

DOI: 10.17235/reed.2020.7233/2020

Letter

Biopsy for hepatocellular carcinoma: only occasionally

DOI: 10.17235/reed.2020.6935/2020

Letter

Medullary colorectal carcinoma. Do we really know it?

DOI: 10.17235/reed.2020.6728/2019

Letter

Signet ring cell carcinoma in a juvenile polyp

DOI: 10.17235/reed.2019.6299/2019

Letter

The rectosigmoid junction: are limits important?

DOI: 10.17235/reed.2019.5983/2018

Letter

Mantle cell lymphoma of the cecum

DOI: 10.17235/reed.2019.5936/2018

Letter

Primary squamous cell carcinoma of the stomach: a rare entity

DOI: 10.17235/reed.2018.5900/2018

Editorial

Colorectal cancer screening and survival

DOI: 10.17235/reed.2018.5870/2018

Letter

Why anal cytology is not enough in a dysplasia screening program

DOI: 10.17235/reed.2018.5678/2018

Editorial

The right colon challenge

DOI: 10.17235/reed.2018.5544/2018

Digestive Diseases Image

Immune mediated colitis caused by lung cancer treatment with atezolizumab

DOI: 10.17235/reed.2017.5060/2017

Letter to the Editor

Liver metastasis from colorectal cancer 12 years after liver transplantation

DOI: 10.17235/reed.2017.4507/2016

Letter to the Editor

Alopecia areata as a paraneoplastic syndrome of gastric cancer

DOI: 10.17235/reed.2016.4455/2016

Case Report

Hemobilia due to intracholecystic papillary neoplasm

DOI: 10.17235/reed.2016.4205/2016

Review

Serrated lesions and serrated polyposis syndrome

DOI: 10.17235/reed.2017.4065/2015

Letter to the Editor

Endobronchial metastases of colorectal cancer

DOI: 10.17235/reed.2016.4080/2015

Case Report

Primary squamous cell carcinoma of the rectum: an atypical histology

DOI: 10.17235/reed.2016.3975/2015

Citation tools
Sánchez Cánovas M, López Martín A, Montenegro Luis S, Sánchez Saura A. Immune-mediated colitis secondary to treatment with nivolumab-ipilimumab in a patient with stage IV kidney cancer: what do we do when corticosteroids fail?. 8632/2022


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1738 visits.
This article has been downloaded 219 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 21/01/2022

Accepted: 25/01/2022

Online First: 27/01/2022

Published: 07/09/2022

Article Online First time: 6 days

Article editing time: 229 days


Share
This article has been rated by 4 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology